SEC Form D · Amendment · filed July 14, 2016
Deciphera Pharmaceuticals, LLC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
James A. Bristol, Ph.D · Waltham, MADirectorJohn A. Martin · Waltham, MADirectorMichael Taylor · Waltham, MAExec · DirectorOliver F. Rosen, M.D · Waltham, MAExecDaniel F. Flynn, Ph.D · Waltham, MAExecDennis A. Walsh · Waltham, MADirectorLiam A. Ratcliffe, M.D., Ph.D · Waltham, MADirectorThomas F. Kelly · Waltham, MAExecAlok Kejriwal · Ebene, O4DirectorRajesh Khona · Ebene, O4Exec · DirectorNavin Dussoruth · Ebene, O4DirectorAnil Narang · Ebene, O4ExecMichael A. Ross · Herndon, VADirectorJoe Anstine · Columbus, OHExec · DirectorCharles J. O'Hanlon · Pittsburgh, PADirectorWilliam J. Mitchell · Pittsburgh, PAExec · DirectorKirsten Green · New York, NYExecDavid Fialkow · New York, NYExecRobert Wolfson · New York, NYDirectorDouglas Ricket · Saratoga, CADirectorDelfino Hernandez Iii · Mill Creek, WAExecMichael A. Ross · Herndon, VADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗